BIOHAVEN ORD - COM (BHVN)

Historical Holders from Q2 2017 to Q3 2025

Symbol: BHVN on NYSE
Type / Class: Equity / COM
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 897,569
Holdings value: $13,471,987
Number of holders: 2

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025 BIOHAVEN ORD - COM (BHVN) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 897,569 shares of the company stock as of 30 Sep 2025.

Institutional Holders of BIOHAVEN ORD - COM (BHVN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	897,569	$13,471,987				$14.90	2
2025 Q2	897,569	$12,664,245	+$929,413			$14.01	2
2025 Q1	831,679	$19,993,331	+$1,437,703			$23.90	2
2024 Q4	767,787	$28,676,844	+$1,541,546			$37.35	2
2024 Q3	724,310	$36,193,770	+$322,900			$49.97	3
2024 Q2	717,875	$24,917,440	+$7,639,254			$34.71	3
2024 Q1	497,787	$27,223,971	$0			$54.69	2
2023 Q4	497,787	$21,305,283	+$315,222			$42.80	2
2023 Q3	490,422	$12,755,876	+$1,040,400			$26.01	1
2023 Q2	450,422	$10,774,092	-$4,905,321			$23.92	1
2023 Q1	562,981	$11,058,085	-$1,068,548			$28.62	2
2022 Q4	592,793	$13,847,248	-$8,397,127,714	$0	$0	$13.88	7
2022 Q3	57,130,504	$8,636,252,033	-$528,721,546	$170,897,000	$380,951,000	$151.17	226
2022 Q2	58,154,179	$8,410,295,674	-$183,695,364	$27,160,000	$61,096,000	$145.71	314
2022 Q1	63,791,759	$7,563,491,987	+$223,861,844	$80,300,000	$112,294,000	$118.57	292
2021 Q4	60,710,171	$8,367,159,749	+$250,311,863	$121,623,000	$127,402,000	$137.81	271
2021 Q3	58,813,527	$8,168,798,111	-$41,045,866	$70,497,000	$84,137,000	$138.91	242
2021 Q2	58,312,554	$5,660,998,908	+$5,985,538	$77,413,000	$84,932,000	$97.08	217
2021 Q1	58,831,017	$4,021,761,882	+$308,672,278	$47,565,000	$30,363,000	$68.35	219
2020 Q4	55,624,178	$4,767,560,689	-$321,490,438	$144,316,880	$237,577,548	$85.71	231
2020 Q3	60,090,322	$3,900,339,052	+$35,778,071	$40,260,000	$78,166,000	$65.01	210
2020 Q2	59,462,210	$4,343,951,549	+$148,504,131	$35,012,000	$151,683,000	$73.11	217
2020 Q1	57,213,598	$1,944,681,401	+$285,740,553	$15,355,000	$109,446,000	$34.03	170
2019 Q4	49,054,392	$2,670,276,973	-$6,236,108	$38,929,000	$177,851,000	$54.44	182
2019 Q3	48,931,034	$2,041,372,571	+$166,705,909	$18,725,000	$149,566,000	$41.72	181
2019 Q2	45,791,202	$2,003,131,181	+$319,350,777	$44,568,000	$149,553,000	$43.79	192
2019 Q1	38,415,597	$1,977,238,206	+$14,479,031	$21,135,000	$44,416,000	$51.47	167
2018 Q4	37,948,547	$1,403,332,615	+$242,149,091	$5,880,000	$9,276,000	$36.98	126
2018 Q3	29,373,567	$1,102,735,128	-$40,430,427	$1,434,000	$12,271,000	$37.55	114
2018 Q2	30,408,471	$1,201,749,240	+$118,307,615	$2,312,000	$18,440,000	$39.52	99
2018 Q1	27,913,924	$714,021,838	+$196,404,465	$6,676,000	$28,113,000	$25.76	96
2017 Q4	20,058,322	$541,164,762	+$87,999,783	$394,000	$3,821,000	$26.98	88
2017 Q3	15,662,717	$583,610,799	+$84,828,083			$37.38	72
2017 Q2	13,466,804	$332,999,200	+$332,999,256			$25.00	66